Kathryn H Morelli

Jackson Laboratory

$210,284

Attributed

$210,284

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $65.3K · FY2017–21

$100K$75K$50K$25K$0

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$210,284 · 2

By mechanism

F32$160,817 · 1

F31$49,467 · 1

Top collaborators

No co-investigators on record.

Most similar at Jackson Laboratory

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Proteins”

John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
Susan Abushakra · Alzheon, Inc.$47,265,244
Susan M Landau · University Of California Berkeley$47,252,026
Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154

Research focus

ProteinsAdultNervous System DisorderToxic EffectInsightGenesGene TherapyMouse ModelPathway InteractionsAdeno-Associated Viral VectorPathologicDesignEffective TherapyInheritedBcar1 GeneAlternative SplicingDna ShufflingCodeDominant-Negative MutationEngineeringClinical TranslationCytoplasmDeep SequencingAttention

Grant awards (5)

Development of RNA-Directed Therapeutics for Myotonic Dystrophy Type 1 Neuropathology$34,281

F32 · FY2021 · NS · contact PI

Development of RNA-Directed Therapeutics for Myotonic Dystrophy Type 1 Neuropathology$65,310

F32 · FY2020 · NS · contact PI

Development of RNA-Directed Therapeutics for Myotonic Dystrophy Type 1 Neuropathology$61,226

F32 · FY2019 · NS · contact PI

A Personalized Gene Therapy Approach for Charcot-Marie-Tooth Disease$15,217

F31 · FY2018 · NS · contact PI

A Personalized Gene Therapy Approach for Charcot-Marie-Tooth Disease$34,250

F31 · FY2017 · NS · contact PI